|
Real-time Estimate
Cboe BZX
13:15:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 14.42 USD | +0.03% |
|
-9.90% | - |
| 10-22 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 10-20 | Drug developer Lycia Therapeutics targets $938 million valuation in US IPO | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IAMBIC THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +0.10% | -9.90% | - | - | - | 683M |  | | |
- Stock Market
- Stocks
- IAM Stock
- Charts Iambic Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
